Hims & Hers Expands Into Canada After Acquiring Digital Health Platform Livewell
Hims & Hers Health, a leading US digital health company, has officially expanded its services into Canada. This move follows its recent acquisition of Livewell, a Canadian digital health platform known for providing weight loss and wellness services.
The expansion allows Hims & Hers to offer Canadian customers access to affordable and personalized health care solutions. The company, which has a strong presence in the US and Europe, is now better positioned to serve a wider international audience.
This development comes as Canada prepares for the arrival of the first generic semaglutide weight loss drugs. Hims & Hers is planning to launch its own Canadian weight loss program in 2026, in line with the availability of these new treatments.
News of the expansion led to a rise in Hims & Hers' stock price.
Hims & Hers is a digital health company that provides people with access to health and wellness treatments online, including medications for weight loss and other conditions.
The company expanded into Canada to reach more customers and offer its health services in a new market, especially as demand grows for weight loss treatments.
Semaglutide is a medication used for weight loss and diabetes. Its generic version is expected to become available in Canada soon, which will allow more people to access weight loss treatments at a lower cost.
After announcing the expansion, Hims & Hers saw its stock price go up.
Business Wire
Investors Business Daily
Proactive Investors
Zacks Investment Research
CNBC Television